Advertisement

International Journal of Hematology

, Volume 108, Issue 4, pp 443–446 | Cite as

Successful hemostatic management of major surgery for cervical spondylotic myelopathy in a patient with severe factor XI deficiency

  • Yoshiyuki Ogawa
  • Kunio Yanagisawa
  • Yuri Uchiyama
  • Naoki Akashi
  • Tokue Mieda
  • Haku Iizuka
  • Madoka Inoue
  • Reiko Shizuka
  • Masami Murakami
  • Naomichi Matsumoto
  • Hiroshi Handa
Case Report
  • 117 Downloads

Abstract

Factor XI deficiency (FXID) is a rare bleeding disorder caused by mutations in the F11 gene. Spontaneous bleeding in patients with factor XI deficiency is rare, but major bleeding may occur after surgery or trauma. The basic method for hemostatic treatment is replacement of the missing factor using FXI concentrate or fresh frozen plasma (FFP). We report the case of a 72-year-old male with severe FXID who underwent a laminoplasty under sufficient, but minimal, FFP transfusion. Through detailed monitoring of activated partial thromboplastin time (APTT) and FXI activity at the perioperative period, we succeeded in hemostatic management of major surgery without significant blood loss and fluid overload. From the course of this case, we found that measuring FXI activity is superior to measuring APTT. Furthermore, we identified a novel homozygous mutation in F11 [NM_000128.3:c.1041C > A:p.(Tyr347*)] by whole exome sequencing.

Keywords

Factor XI deficiency Hemostatic management Fresh frozen plasma (FFP) Major surgery Whole exome sequencing Causative F11 mutation 

Notes

Acknowledgements

N. M. and H. H. conceived the study. N. M., Y. O. and Y. U. designed the study. Y. O., K. Y., N. A. and H. H. evaluated patients and provided samples. T. M. and H. I. conducted a surgery. M. I. and M. M. performed a clinical test. Y. U. performed WES analyses. Y. O., H. H., Y. U. and N. M. wrote the manuscript. All authors reviewed the manuscript.

Compliance with ethical standards

Conflict of interest

The authors stated that they had no interests which might be perceived as posing a conflict or bias.

References

  1. 1.
    Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med. 1991;325:153–8.CrossRefGoogle Scholar
  2. 2.
    Kato A, Asakai R, Davie EW, Aoki N. Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4. Cytogenet Cell Genet. 1989;52:77–8.CrossRefGoogle Scholar
  3. 3.
    Colakoglu S, Bayhan T, Tavil B, Keskin EY, Cakir V, Gümrük F, et al. Molecular genetic analysis of the F11 gene in 14 Turkish patients with factor XI deficiency: identification of novel and recurrent mutations and their inheritance within families. Blood Transfus. 2016;4:1–8. (Epub).Google Scholar
  4. 4.
    James P, Salomon O, Mikovic D, Peyvandi F. Rare bleeding disorders- bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency. Haemophilia. 2014;20(Suppl. 4):71–5.Google Scholar
  5. 5.
    Duga S, Salomon O. Congenital factor XI deficiency: an update. Semin Thromb Hemostasis. 2013;39:621–31.CrossRefGoogle Scholar
  6. 6.
    Di Paola J, Nugent D, Young G. Current therapy for rare factor deficiencies. Haemophilia. 2001;7(Suppl 1):16–22.CrossRefGoogle Scholar
  7. 7.
    Japanese Orthopaedic Association. Scoring system for cervical myelopathy. J Jpn Orthop Assoc. 1994;68:490–503. (Japanese).Google Scholar
  8. 8.
    Iwama, et al. J Hum Genet. 2016;61(6):527–31.  https://doi.org/10.1038/jhg.2016.9.CrossRefPubMedGoogle Scholar
  9. 9.
    Collins PW, Goldman E, Lilley P, Pasi KJ, Lee CA. Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrate. Haemophilia. 1995;1:227–31.CrossRefGoogle Scholar
  10. 10.
    Takahashi Y, Arai M, Kawada T, Hagiwara T, Amano K, Isogai N, et al. Management of a patient with factor XI deficiency in total hip joint replacement by plasma exchange transfusion. Jpn J Thromb Hemost. 1995;6(1):22–6. (Japanese).CrossRefGoogle Scholar
  11. 11.
    Pinke GN, Cumming AM, Thachil J, Hay CR, Burthem J, Bolton-Maggs PH. Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency. Haemophilia. 2017;23(2):273–83.CrossRefGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2018

Authors and Affiliations

  • Yoshiyuki Ogawa
    • 1
  • Kunio Yanagisawa
    • 1
  • Yuri Uchiyama
    • 1
    • 2
  • Naoki Akashi
    • 1
  • Tokue Mieda
    • 3
  • Haku Iizuka
    • 3
  • Madoka Inoue
    • 4
  • Reiko Shizuka
    • 4
  • Masami Murakami
    • 5
  • Naomichi Matsumoto
    • 2
  • Hiroshi Handa
    • 1
  1. 1.Department of HematologyGunma University Graduate School of MedicineMaebashiJapan
  2. 2.Department of Human GeneticsYokohama City University Graduate School of MedicineYokohamaJapan
  3. 3.Department of Orthopaedic SurgeryGunma University HospitalMaebashiJapan
  4. 4.Clinical Laboratory CenterGunma University HospitalMaebashiJapan
  5. 5.Department of Clinical Laboratory MedicineGunma University Graduate School of MedicineMaebashiJapan

Personalised recommendations